O'Hara Kevin P, Executive Vice President at HealthStream (HSTM), has demonstrated a consistent pattern of selling activity over multiple transactions, with no recorded purchases in the available SEC Form 4 filings. Since August 2025, O'Hara has executed 24 trades exclusively involving HSTM shares, all of which were sales or related transactions such as option exercises (coded "M" and "F") and awards (coded "A"). Notably, the two most recent sales occurred on December 8, 2025, and August 27, 2025, totaling $48,520 and $55,936, respectively. Smaller transactions tied to derivative securities, including a $6,165 sale on September 29, 2025, and a $4,830 sale on October 30, 2025, further underscore the selling trend.
The filings reveal that O'Hara's transactions are concentrated in HealthStream, with no diversification across other companies. While many filings reflect derivative-related adjustments with no reported value (coded "M" or "A"), the monetized sales—particularly the two largest in late 2025—account for the bulk of the $175,723 in total proceeds. The absence of any buy transactions suggests a one-sided disposition, though the sales could represent routine portfolio management rather than a directional stance on the company. The most recent activity, including a $30,904 sale on February 27, 2026, and a $29,368 sale on March 30, 2026, continues this pattern, reinforcing a clear divestment bias over the observed period.
AI-assisted summary